AACR Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Subcommittees a |
Co-Chairs |
Joyce O’Shaughnessy, M.D., Baylor-Sammons Cancer Center, US Oncology, Dallas, TX |
Gary J. Kelloff, M.D., DCTD, National Cancer Institute, Bethesda, MD |
Gary B. Gordon, M.D., Ovation Pharmaceuticals, Lincolnshire, IL |
Richard Pazdur, M.D., Division of Oncology Drug Products, |
U.S. Food and Drug Administration, Rockville, MD |
Background and Conceptual Foundations |
Gary J. Kelloff, M.D., Chairperson |
Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD |
Caroline C. Sigman, Ph.D., Vice Chairperson |
CCS Associates, Mountain View, CA |
David L. De Mets, Ph.D. |
University of Wisconsin, Madison, WI |
Margaret Foti, Ph.D. |
AACR, Philadelphia, PA |
Peter Greenwald, M.D., Dr.P.H. |
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD |
Florence Houn, M.D. |
Office of Drug Evaluation III, U.S. Food and Drug Administration, Rockville, MD |
Robert J. Temple, M.D. |
Office of Drug Evaluation, U.S. Food and Drug Administration, Rockville, MD |
Anthony M. Tremblay |
AACR, Philadelphia, PA |
Daniel D. Von Hoff, M.D. |
Arizona Cancer Center, University of Arizona, Tucson, AZ |
Prostate and Bladder Cancers |
Peter T. Scardino, M.D., Chairperson |
Memorial Sloan-Kettering Cancer Center, New York, NY |
William G. Nelson, M.D., Ph.D., Vice Chairperson |
Johns Hopkins Oncology Center, Baltimore, MD |
Ivan D. Horak, M.D. |
Pharmacia, Peapack, NJ |
Ronald Lieberman, M.D. |
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD |
Scott M. Lippman, M.D. |
The University of Texas M. D. Anderson Cancer Center, Houston, TX |
Wael A. Sakr, M.D. |
Wayne State University, Harper Hospital, Detroit, MI |
Dan Shames, M.D. |
Urologic Drugs, U.S. Food and Drug Administration, Rockville, MD |
Colorectal Cancer |
Gary B. Gordon, M.D., Ph.D., Chairperson |
Ovation Pharmaceuticals, Lincolnshire, IL |
Monica M. Bertagnolli, M.D., Vice Chairperson |
Brigham and Women’s Hospital, Boston, MA |
Carolyn R. Aldige |
Cancer Research Foundation of America, Alexandria, VA |
Steven D. Averbuch, M.D. |
AstraZeneca Pharmaceuticals, Wilmington, DE |
Mark I. Avigan, M.D. |
Division of Gastrointestinal and Coagulation Drug Products, U.S. Food and Drug Administration, Rockville, MD |
Stephen B. Baylin, M.D. |
Johns Hopkins School of Medicine, Baltimore, MD |
Charles W. Boone, M.D., Ph.D. |
Massachusetts Institute of Technology, Cambridge, MA |
Ernest T. Hawk, M.D., M.P.H. |
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD |
Richard Pazdur, M.D. |
Division of Oncology Drug Products, U. S. Food and Drug Administration, Rockville, MD |
Lilia Talarico, M.D. |
Division of Gastrointestinal and Coagulation Drug Products, U.S. Food and Drug Administration, Rockville, MD |
Breast Cancer |
Carol J. Fabian, M.D., Chairperson |
University of Kansas Medical Center, Kansas City, KS |
Joyce O’Shaughnessy, M.D., Vice Chairperson |
Baylor-Sammons Cancer Center, US Oncology, Dallas, TX |
Matthew S. Mayo, Ph.D. |
University of Kansas Medical Center, Kansas City, KS |
Robert Milsted, M.D. |
AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, UK |
Michael B. Sporn, M.D. |
Dartmouth Medical School, Hanover, NH |
Anna Marie V. Storniolo, M.D. |
Eli Lilly & Company, Indianapolis, IN |
Frances M. Visco, J.D. |
National Breast Cancer Coalition, Washington, DC |
Grant Williams, M.D. |
Division of Oncology Drug Products, U.S. Food and Drug Administration, Rockville, MD |
Aerodigestive Cancers |
Andrew J. Dannenberg, M.D., Chairperson |
Weill Medical College of Cornell University, Strang Cancer Prevention Center, New York, NY |
Waun Ki Hong, M.D., Vice Chairperson |
The University of Texas M.D. Anderson Cancer Center, Houston, TX |
Steven E. Benner, M.D. |
Bristol-Myers Squibb, Wallingford, CT |
Adi F. Gazdar, M.D. |
University of Texas Southwestern Medical Center, Hamon Cancer Center, Dallas, TX |
Walter Hittelman, Ph.D. |
The University of Texas M.D. Anderson Cancer Center, Houston, TX |
David A. Katzka, M.D. |
University of Pennsylvania, Philadelphia, PA |
Stephen Lam, M.D. |
British Columbia Cancer Center, Vancouver, BC, Canada |
Beverly D. Lyn-Cook, Ph.D. |
National Center for Toxicology Research, Jefferson, AR |
Vali Papadimitrakopoulo, M.D. |
The University of Texas M.D. Anderson Cancer Center, Houston, TX |
Anil K. Rustgi, M.D. |
University of Pennsylvania, Philadelphia, PA |
Lee W. Wattenberg, M.D. |
University of Minnesota, Minneapolis, MN |
Gynecological and Skin Cancers |
Michele Follen, M.D., Chairperson |
The University of Texas M.D. Anderson Cancer Center, Houston, TX |
Frank L. Meyskens, Jr., M.D., F.A.C.P., Vice Chairperson |
Chao Family Comprehensive Cancer Center, University of California, Irvine, CA |
David S. Alberts, M.D. |
Arizona Cancer Center, Tucson, AZ |
Vicki V. Baker, M.D. |
Wayne State University and The Karmanos Cancer Institute, Ann Arbor, MI |
Molly A. Brewer, D.V.M., M.D. |
The University of Texas Houston Medical School and M.D. Anderson Cancer Center, Houston, TX |
Patricia Keegen, M.D. |
Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD |
David G. Mutch, M.D. |
Washington University, St. Louis, MO |
Mack T. Ruffin, M.D., M.P.H. |
University of Michigan, Ann Arbor, MI |
Steven P. Stratton, Ph.D. |
Arizona Cancer Center, University of Arizona, Tucson, AZ |
Jeffrey S. Weber, M.D., Ph.D. |
University of Southern California, Los Angeles, CA |
a FDA participation in this Task Force does not represent or imply endorsement of the views of this publication by the Agency or the United States government.